NCT06414720View on ClinicalTrials.gov

Salivary microRNA in Endometriosis: Correlation With Response to Progestin Therapy

RecruitingOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

April 22, 2024

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
Endometriosis
Interventions
DRUG

Dienogest 2 MG

The patients will be started on progestin therapy after a saliva sample is collected from them for miRNA analysis.

Trial Locations (1)

33100

RECRUITING

University of Udine, Udine

All Listed Sponsors
lead

University of Udine

OTHER